Longewell And Associates

Cases

 

We present these various legal decisions which we feel are important in the area of Food and Drug law:

 

Case #01:

Combination product case:
Bracco Diagnostics, Inc, v. Shalala, 963 F. Supp. 20
(DC District April 21, 1997)

Case #02:

FDA and Free Speech #01:
Washington Legal Foundation v. Henney
(202 F. 2d 331, US Ct. Appeals, DC cir. Feb 11, 2000)

Case #03:

Patents and investigational use:
Nexell Therapeutics v. AmCell Corp.
(2002 US Dist. Lexis 7308, April 2002, 143 F. Supp. 2d 401, 2001)

Case #04:

Management Responsibility:
“The Boss is Only Guilty if He’s Really in Charge” US v. Park
(421 U.S. 65, JUNE 1975)

Case #05:

FDA and Free Speech #02:
Thompson v. Western States
(US Supreme Court, Slip Op No. 01-344, 535 US, 2002)

Case #06:

Here’s a Bad Tip From Bard:
Don’t Ask, Don’t Tell FDA
U.S. v. C.R. Bard, Inc. 848 F. Supp. 287 (Mass. 1994)

Case #07:

United States of America v. Barr Labs, Inc.
812 F. Supp 458, 3/30/93
GMP Lessons From a Federal Judge

Case #08:

Defining the Domain of Medical Device Preemption
(Medtronic V. Lohr 518 U.S. 470, 1996)

Case #09:

FDA has only the Authority Congress Grants
(Association of American, Physicians and Surgeons, Inc. V. FDA  2002 U.S. Dist Lexis 19689)

Case #10:

Drug Development an IP Wasteland?
Merck KGaA v Integra Life Sciences Ltd., 545 US __(2005)  Slip Op. 03-1237

Case #11:

Many Roads Lead to Rome – FDA is Not Sole Arbiter of What QSR Compliance Requires
United States of America v Utah Medical Products

  • People
  • Practice Areas
  • Compliance
  • International
  • Cases
  • News
  • Contact Us

The information contained in this site is for general information only, and is not legal or regulatory advice about the compliance of any activity with current law or regulation.

Website Design by Tierra Interactive

Copyright 2008-2013 Longwell & Associates